.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Mallinckrodt
Colorcon
Medtronic
Healthtrust
Novartis
US Army
Cantor Fitzgerald
Moodys

Generated: June 26, 2017

DrugPatentWatch Database Preview

LODINE XL Drug Profile

« Back to Dashboard

Which patents cover Lodine Xl, and when can generic versions of Lodine Xl launch?

Lodine Xl is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in LODINE XL is etodolac. There are twenty-two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the etodolac profile page.

Summary for Tradename: LODINE XL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list57
Clinical Trials: see list1
Patent Applications: see list7,538
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LODINE XL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-001Oct 25, 1996DISCNNoNo► Subscribe► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-003Jan 20, 1998DISCNNoNo► Subscribe► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-002Oct 25, 1996DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LODINE XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-001Oct 25, 19964,966,768*PED► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-002Oct 25, 19964,966,768*PED► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-003Jan 20, 19984,966,768*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Covington
McKinsey
Argus Health
Daiichi Sankyo
AstraZeneca
Citi
Queensland Health
Teva
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot